[Immunoscore and Its Predictive Value for Colorectal Cancer].

Area of Science:

• Oncology
• Immunology
• Cancer Diagnostics

Context:

• Clinical outcomes vary significantly within the same TNM stage, indicating limitations of current cancer staging.
• Tumor microenvironment and immune cell infiltration are critical factors influencing cancer progression and patient prognosis.
• Existing TNM classification may not fully capture the prognostic variability observed in cancer patients.

Purpose:

• To evaluate the prognostic value of Immunoscore methodology in a large cohort of colorectal cancer patients.
• To assess the correlation between immune cell infiltration (CD8+, CD3+ lymphocytes) and patient outcomes, including treatment response, progression, and survival.
• To determine if Immunoscore can provide superior prognostic information compared to the AJCC/UICC TNM classification.

Summary:

• Immunoscore quantifies immune cell density and localization within tumor tissue and the invasive margin.
• An international collaboration involving over 7,000 colorectal cancer patients is evaluating Immunoscore.
• Inverse correlation observed between T-lymphocyte density (CD8+, CD3+) and tumor stage; higher densities are linked to better survival, reduced relapse, and fewer metastases.

Impact:

• High T-lymphocyte infiltration in tumors is associated with significantly longer asymptomatic survival and overall survival.
• Immunoscore has the potential to refine cancer prognostication beyond TNM staging.
• The findings support the integration of Immunoscore into routine cancer diagnostics for improved patient management.